Change the Shape of your Clinical Development

Together, enhancing research with patient- and science-driven insight

OUR DNA

Over 50 Years of Unparalleled Client Service

Building on a foundation of innovation and science, the lineage of Cerba Research is reflected in the breadth of our services. That includes expanded central lab, biomarker, IVD, and CDx offerings, as well as support from research and development through clinical studies and commercialization of therapies.

Our intent is to change the way drug development is achieved with our combined translational biomarker offerings. Our passion, expertise, and commitment to quality drive Cerba Research to become the new standard for changing the shape of your clinical development, and for helping patients around the world get access to new treatments faster.

Our Mission

Leverage patient data and scientific insight to shape and advance clinical trials by providing customized laboratory solutions to support global biotech, pharma, IVD, and research organizations to improve the lives of patients around the world.

Our Vision

Change the paradigm of clinical trial conduct and enable the acceleration of novel therapies by delivering scientific insights and leveraging vast patient data.

Innovation

Since 1983, Cerba Research has been synonymous with innovation, and our identity is indivisible from our tireless pursuit of the breakthroughs that change patient lives.

Cerba Research Values

Courage

Cerba Research’s strength is born of its flexibility and courage; as the needs of patients, clients, and employees change, we can only be as agile as we are courageous.

Commitment

Every conversation at Cerba research begins with a commitment to transparency, excellence and honesty, ensuring actions based on integrity and quality follow.

Empower

Cerba Research hires the best employees specifically so we can empower them to fulfill their full potential — this growth is the engine that drives the company forward.

Patients

The patient is at the heart of everything Cerba Research does and is our nonnegotiable first priority.

Our Evolution

The Cerba Research legacy began in 1967 with the establishment of Laboratoire CERBA, a leading European laboratory in specialized biology. The timeline below shows how Cerba Research has evolved since, through organic growth and partnerships.

2021

2021 CERBACT ASIA, IMMUNO-ONCOLOGY CENTER OF EXCELLENCE

In August, Cerba Research and ACT Genomics joined to create a purpose-built lab facility in Taiwan to support new growth areas for biotech and pharma clients globally and drive better patient outcomes across all phases of clinical trials.

2021

2021 BIOKORTEX PARTNERSHIP

Cerba partners with Biokortex, a provider of digital solutions to the healthcare sector. The partnership allows us to provide our customers with patient identification and recruitment solutions by leveraging patient biological and medical data.

2020

2020 HISTALIM, CERBA XPERT & BARC LAB BECOME CERBA RESEARCH

We kicked off 2020 strongly by launching Cerba Research, weaving three of the Cerba Healthcare companies into one to provide better solutions to our clients and to the patients they serve. Learn More

2019

2019 OWL METABOLOMICS PARTNERSHIP

Cerba partners with Vizcaya, Spain’s OWL Metabolomics, providing our customers with solutions to develop tailored treatments for NASH patients.

2019

2019 PPC (TAIWAN) PARTNERSHIP

Cerba partners with clinical and laboratory services provider PPC Taiwan, further expanding its Asian footprint.

2018

2018 BARC BECOMES BARC LAB

At the end of a year marked by growth and change, BARC becomes Barc Lab.

2018

2018 CERBA HEALTHCARE/LANCET AFRICA JOINT VENTURE

Cerba Healthcare and Lancet Laboratories launch a joint venture, Cerba Lancet Africa, combining the strength and knowledge of our leading European laboratories with Lancet’s specialized labs throughout Africa.

2018

2018 TEDDY LAB PARTNERSHIP (CHINA)

Cerba partners with Shanghai, China’s Teddy Lab, allowing us to offer our clients a wider range of testing in China.

2018

2018 ACQUISITION OF HISTALIM

Cerba broadens its expertise once more by acquiring HISTALIM, a histopathology and immunohistochemistry specialty lab in 2005 in Montpellier, France.

2015

2015 CERBA LAB TO CERBA HEALTHCARE

Having grown to encompass medical laboratories and a global central lab fostering clinical trials all over the world, it was time for a name change. Cerba Lab becomes Cerba Healthcare.

2012

2012 BARC CHINA FOUNDED

The founding of BARC’s China office expands our global footprint.

2012

2012 Cerba Xpert Founded

Cerba Xpert, provider of tailor-made solutions to evaluate IVD devices and developer of quality control solutions, was created in 2012.

2009

2009 SRL MEDISEARCH PARTNERSHIP

Cerba partners with Tokyo, Japan’s SRL Medisearch to better support clinical trials on a global scale.

2007 BARC Acquired by Cerba Lab

2007 BARC Acquired by Cerba Lab

BARC is acquired by Cerba Lab, combining the strengths of the expert laboratories in France with the expertise and knowledge of our global central lab.

Cerba Cerba
2001

2001 BARC USA FOUNDED

BARC’s first physical presence in the United States arrives with the opening of our New York central lab, increasing our worldwide presence to four continents.

1999

1999 BARC RSA/LANCET JOINT VENTURE

BARC forms a joint venture with Lancet Laboratories, one of the leading pathology laboratories throughout Africa.

1997

1997 BARC AUS FOUNDED

BARC increases its global footprint, opening a new office in Australia.

1996

1996 BARC RSA FOUNDED

BARC RSA becomes our first office on a different continent, as our South African expansion joins our European office.

1983

1983 BARC EUROPE FOUNDED

BARC’s (Bio Analytical Research Corporation) journey starts in Ghent, Belgium, where our headquarters remains to this day, anchoring our global presence.

1998

1998 ACQUISITION OF SPECIALISED MEDICAL BIOLOGY CENTRE OF THE PASTEUR INSTITUTE

Cerba adds to its expertise and knowledge by acquiring the Specialized Medical Biology Center of the Pasteur Institute, an infectious diseases specialist.

1991

1991 ACQUISITION OF IPECA

24 years later, Cerba expands by acquiring IPECA, an expert anatomy and pathological cytology LAB.

1967

1967 Cerba Lab Founded

Cerba’s journey starts in France with the founding of their first laboratory specializing in medical biology.

This is Cerba Research

What does Cerba Research do? Where are we located? How do we shape clinical development all over the world? This one-minute video gives you a quick overview of our company.

Read Our Latest News

For over 50 years, Cerba Research has evolved in one direction: toward better serving our customers. From corporate acquisitions to international expansions to everyday decision-making, one question guides our approach: Will this help us to better serve our customers?

The unsurpassed innovation of our combined translational biomarker offerings, combined with the full resources of our expert scientists, achieve their maximum potential only through a true partnership with you. We understand that to your customers, our performance is your performance — and that your reputation is on the line with every deadline and each deliverable.

It is within our grasp, today, to usher in the next generation of protocol conduct. As your partner, Cerba Research empowers you to bring new, life-changing therapies to patients worldwide.

We can change the shape of your clinical development. Together, enhancing research with patient- and science-driven insight.

Let's Get Started